InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Imran Talat, Chairman & CEO. Insider active across 1 company, notably Rani Therapeutics Holdings, Inc.. Aggregated, 3 filings have been logged. Activity tracked since 3 February 2022. The latest transaction was disclosed on 22 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
86,600 shares0Class A Common StockSEC:0001209191-22-021022:0
827,467 shares0Class A Common StockSEC:0001209191-22-007647
827,467 shares0Class A Common StockSEC:0001209191-22-007647:0
3 of 3 declarations
About Imran Talat
Talat Imran is the Chief Executive Officer of Rani Therapeutics Holdings, Inc. He leads the company with a focus on innovation in the biotechnology field. His strategic leadership aims to develop advanced therapeutic solutions to improve patient health.
